The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR -Mutant NSCLC Patients Treated with First-Line Osimertinib.
OncoTargets and therapy(2023)
摘要
Baseline serum NLR could act as an important prognostic marker for -mutant NSCLC patients receiving first-line osimertinib. A high NLR was associated with higher metastatic burden, more extrathoracic metastases, and therefore, a worse outcome.
更多查看译文
关键词
neutrophil-to-lymphocyte,egfr-mutant,first-line
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要